Notably, the quantification of DCTPP1 expression in cell lines after the exposure to chemotherapeutic compounds corroborated these findings, showing higher DCTPP1 levels in luminal A cell lines compared to triple-negative breast cancer (TNBC). This evidence concerns the gene DCTPP1 and triple-negative breast carcinoma.